SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Price analytics
Returns
1 day
-7.9%
1 week
-9.4%
1 month
-15.9%
3 months
-46.3%
6 months
-51.7%
1 year
-65.9%
3 years
-50.8%
Risk
Volatility (1y ann.)
54.6%
Beta vs ASX 200
0.45
Sharpe (1y)
-1.77
VaR 95% (1-day)
-5.6%
Max drawdown (1y)
-67.4%
Off 1-year high
-67.4%
Technicals
RSI(14)
39
vs 50DMA
-19.5%
vs 200DMA
-47.5%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value67.5
Trailing P/E
—
Forward P/E
84
PEG ratio
80
EV / EBITDA
6
Price / Book
92
Price / Sales
100
Growth92.8
Revenue growth (1y)
100
Revenue CAGR (3y)
86
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health89.2
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
51
Debt / Equity
100
Quality (Profitability & Cash Flow)1.7
Return on equity
0
Return on assets
8
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum0.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
0
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).